Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
B. Pintado Cort (Madrid, Spain), A. Pérez Figuera (Madrid, Spain), C. Rodríguez Calle (Madrid, Spain), D. Velasco Alvarez (Madrid, Spain), F. Xavier León Román (Madrid, Spain), E. Mercedes Noboa (Madrid, Spain), L. Pozuelo Sánchez (Madrid, Spain), A. García Sánchez (Madrid, Spain), E. Mañas Baena (Madrid, Spain), C. Egea Santaolalla (Vitoria-Gasteiz, Spain), J. Durán Cantolla (País Vasco, Spain), A. Muriel (Madrid, Spain), I. Cano Pumarega (Madrid, Spain). Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up.. 2551

Member's Comments

No comment yet.

Related content which might interest you: Association between obstructive sleep apnea and cancer in men in the general population after 20 years of follow-up Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Increased cardiovascular mortality in obstructive sleep apnoea: a 7-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 343s Year: 2001 Obstructive sleep apnea and risk of systemic hypertension among the middle-aged general population women from 30 to 70 years old. A follow-up study Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Effects of CPAP on clinic blood pressure in patients with obstructive sleep apnea: 10 years follow –up Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Obstructive sleep apnoea and risk of cardiovascular disease in men. A follow-up study Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Evaluation of cardiovascular risk after long-term c-PAP therapy in patients with obstructive sleep apnea. A 4-year follow-up Source: International Congress 2015 – Innovations in noninvasive ventilation: is it always gold that glitters? Year: 2015 Disease characteristics and adherence to treatment with continous positive airway pressure in men and women severe obstructive sleep apnea (OSA). Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Twenty years compliance with continuous positive air pressure treatment in patients with severe obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2012; 39: 906-912 Year: 2012 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005 CPAP in the elderly with non-severe obstructive sleep apnea: effect on cardiovascular events and somnolence. Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Age at diagnosis is not related to CPAP use over the first year when treating obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 410s Year: 2006 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Impact of gender on the relationship between obstructive sleep apnoea and hypertension in an otherwise healthy middle-aged sleep clinic cohort Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002